|By Marketwired .||
|April 21, 2014 07:00 PM EDT||
WINNIPEG, MANITOBA -- (Marketwired) -- 04/21/14 -- Miraculins Inc. (TSX VENTURE: MOM) (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs, announces today that David Eichler has stepped down from the Company's Board of Directors.
"The Board wishes to thank David for his effective contributions during his tenure as a director," said Harry Bloomfield Q.C., Chair of the Miraculins Board.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.